Challenges to Uptake of Monoclonal Antibody Therapies for COVID-19: Lessons Learned

By Gina Shaw
Issues identified in the introduction and uptake of monoclonal antibody therapies for COVID-19 offer key insights into gaps and opportunities in how such products are launched in the health care system in the future, Connie Sullivan, BSPharm, the president and CEO of the National Home Infusion Association, said at the group’s 2021 annual conference. “This is important to understand because there certainly will be more products like these in the coming years.”